Remove 2018 Remove Disease Remove Radiation
article thumbnail

Cardiac PET use increases in coronary artery disease

AuntMinnie

PET, CT, and MRI use for assessing coronary artery disease increased in Medicare patients from 2018 to 2022, while SPECT and stress echocardiography declined over the same period, researchers have reported. Taken together, these findings call for efforts to address barriers impeding wider uptake of PET,” the group wrote.

Disease 239
article thumbnail

Targeted radiopharmaceuticals offer new hope for longer 'healthspans'

AuntMinnie

However, increased longevity has brought on a troubling rise in chronic disease, diminishing the quality of life later in life. A 2018 study from the U.S. Centers for Disease Control and Prevention (CDC) found that more than a quarter of U.S. Mark Crockett, MD, chief medical officer at TeleDaaS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PSMA-PET helps plan treatment in men with relapsed prostate cancer

AuntMinnie

To that end, the researchers analyzed the use of the technique from a trial they first launched in 2018. The researchers included a total of 178 with salvage RT plans available who had enrolled in the trial between September 2018 and August 2020 at UCLA and the University of California, San Francisco.

Radiation 278
article thumbnail

How AI has improved CT image reconstruction for cardiac cases

AuntMinnie

Owing primarily to its noise reduction capabilities, DLR has repeatedly been shown to sharply lower radiation dose while maintaining image quality. Around 2018, however, development efforts for DLR began to pick up. Accordingly, commercial and research activity has accelerated.

Imaging 278
article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

His research interests include using structural and functional MRI -- particularly ultrahigh-field, 7-tesla MRI -- to map brain microstructure and develop neurosurgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.

article thumbnail

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

Imaging Technology

2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. sites were treated with GammaTile, a treatment that provides immediate radiation where it is needed most after brain tumor removal surgery. Amsbaugh; Catherine S. Kim (2023).

article thumbnail

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the analysis of Neuromelanin-sensitive MRI

Imaging Technology

While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades. Cassidy, “it allows us to obtain potentially useful adjunctive information about many other diseases such as Alzheimer’s disease, and PTSD.”